06/09/2026
1. The Antiplatelet Effect (Low-Dose / COX-1 Selective)
At low doses, aspirin selectively targets COX-1 in platelets.
COX-1 converts arachidonic acid into Thromboxane A_2 (TXA_2), a powerful vasoconstrictor and platelet aggregator.
Because platelets lack nuclei, they cannot synthesize new enzymes. The COX-1 inhibition lasts for the entire lifespan of the platelet (~7 to 10 days).
Endothelial cells lining the blood vessels do have nuclei. They can synthesize new COX enzymes to maintain production of Prostacyclin (PGI_2), which inhibits platelet aggregation and dilates blood vessels. This creates a net antithrombotic state.
2. Analgesic, Antipyretic, & Anti-inflammatory Effects (High-Dose / COX-1 & COX-2)
At higher doses, aspirin inhibits COX-2, an inducible enzyme expressed during tissue injury and inflammation.
Blocking COX-2 prevents the synthesis of Prostaglandins (specifically PGE_2 and PGI_2), which normally sensitize nociceptors to pain and act on the hypothalamus to elevate body temperature (fever).
Clinical Dosages
Aspirin's clinical utility is highly dose-dependent, fitting into three distinct therapeutic windows:
1. Low Dose (75 mg – 325 mg daily)
Indications: Cardiovascular and cerebrovascular prophylaxis.
Clinical Scenarios: Acute Coronary Syndrome (ACS), secondary prevention of myocardial infarction (MI) or ischemic stroke, and management of stable angina.
Note: In an acute MI setting, a loading dose of 162 mg to 325 mg is given immediately, and the patient is instructed to chew the tablet to accelerate buccal absorption.
2. Intermediate Dose (325 mg – 4000 mg daily, divided)
Indications: Analgesia (pain relief) and antipyresis (fever reduction).
Clinical Scenarios: Mild-to-moderate pain (headaches, dental pain) and transient febrile illnesses. Typically dosed as 325 mg to 650 mg every 4 to 6 hours as needed.
3. High Dose (4000 mg – 8000 mg daily, divided)
Indications: Anti-inflammatory.
Clinical Scenarios: Acute rheumatic fever, Kawasaki disease, and severe inflammatory arthropathies.
Note: High doses are rarely used today for standard arthritis due to the availability of safer, more targeted NSAIDs and biologics.
